MAPT and Alzheimer disease: CSF sPDGFRβ has since been shown to be positively correlated with CSF t-tau and p-tau in two independent cohorts of cognitively unimpaired participants with biomarker changes indicative of a transition from normal ageing to early AD [5, 6].